Page 8 - Benefit Managers News Today

“Full Financial Risk” A. Overview of Key Safe Harbors and Exceptions An important initial consideration is that there are multiple differing requirements between corresponding Stark Law exceptions and AKS safe harbors. Stakeholders must navigate the requirements under both regulatory regimes for arrangements that potentially implicate each law. Although a number of commenters sought a unified set of requirements between Stark Law and AKS requirements, CMS and OIG rejected this approach, not...

Tuesday, February 2, 2021 On 2 December 2020, the U.S. Department of Health and Human Services’ (HHS) issued two Final Rules in conjunction with its “Regulatory Sprint to Coordinated Care,” which will markedly change the regulatory fraud and abuse landscape for “value-based” arrangements: (i) The HHS Office of the Inspector General (OIG) published a Final Rule that introduces new safe harbor protections under the federal Anti-Kickback Statute (AKS) for certain coordinated c...

Facing renewed scrutiny now that epstein has been charged in a new indictment alleging that he sexually abused dozens of other girls. the white house tells axios that it has called off a proposal to recall rebates from the middlemen. benefit managers negotiate reduced prices and keep some of the money for themselves. >> the white house backing away from the idea saying that its encouraged by bipartisan talks to bring down drug prices. this is all bad news for big pharma which blames those midd...

Agreement was negotiated. according to the miami herald, it was still being negotiated. it was already established. acostas role is being questioned. a critical component of president trumps plan to force down drug prices is now dead. the white house tells axios it has called off a proposal to overhaul rebates collected by pharmacy benefit managers. those are the middlemen between insurance companies and benefit managers to negotiate discounted prices but keep some of the rebate money itself. ...

The pharmaceutical companies in a few days or weeks we are going to have the pharmacy benefit managers in. they are the ones involved mostly in the rebate issue. there is 170 billion difference between a list price and what the price the consumer pays, >> neil: i know a lot of drug companies were fingering the benefit managers that coordinate rates between insurers and employers and the drug companies -- this is what theyre saying, are stuck holding the bag. did you believe them? >> no, but im n...

Walgreens. they are all trading higher on friday. one of the key points, these are the biotechs as well. making again naric drugs for low income older people on medicare. this is one of the bright spots. they cant shoot this down. just let people know, one idea when we see all of these is the pharmaceutical companies are going to publicize the cost of the pills. some people say this may shame the pharmaceutical companies into lowering their own prices because they dont want to deal with a p.r. b...

Director and health care analyst at capital street. good to see you, thank you for being with us. >> thank you. >> you and i were here earlier this morning watching that initial market reaction and it seemed very, very serious for something that seems to just be a proposal for the moment. >> agreed. it was an overreaction, i would say. you had pbms dropping like a rock. >> pharmaceutical benefit managers. >> exactly, the middle man. the insurers were down, the hospitals were up slightly. but i w...

Politically too hard for either political base to tolerate the two par ties working together o polarizing right now? >> i have dedicated my professional life and written bipartisan laws and have been signed by presidents of both political parties. look, the point is we have said from the beginning that if republicans said they would not go with a partisan our way or the highway approach which is reck reconciliati reconciliation, we work together. the first thing we do is we stabilize the private...

Beginning that if they would move away from this partisan, our way or the highway approach, we have a number of suggestions to work in a bipartisan way. i have a long history of doing that. the first thing we do is take steps to improve the exchanges, to stabilize the private insurance market. the second thing we would do is focus on prescription drug costs, ive been particularly concerned about the middle men, the pharmaceutical benefit managers. we dont know what theyre putting in their pocket...

Why, thank you. whether its saving for retirement, college, or anything else, contact a fidelity investment professional today. im seema mody with your market wrap. the s&p is off half a point. the nasdaq is lower by 3. opposition to the planned merger of the benefit managers is said to be building. and boeing shares sank 1% after it said dream liners need repairs. thats it from cnbc first in business worldwide. now back to "hardball."